down arrow

Advanced Enzyme

  • Market Cap: Small Cap
  • Industry: Chemicals
  • ISIN: INE837H01020
  • NSEID: ADVENZYMES
  • BSEID: 540025
INR
276.80
7.1 (2.63%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 44.37 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

272.40277.55

52 Week

257.85571.15
Valuation
Technical
Day's Volume

CASH

44.37 k (-57.12%) Volume

Shareholding (Dec 2024)

FII

12.58%

Held by 100 FIIs

DII

8.18%

Held by 8 DIIs

Promoter

42.93%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate -1.20% of over the last 5 years

 
2

Flat results in Dec 24

3

Stock is technically in a Bearish range

4

With ROE of 11.1, it has a Very Expensive valuation with a 2.2 Price to Book Value

5

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Chemicals

stock-summary
Market cap

INR 3,097 Cr (Small Cap)

stock-summary
P/E

21.00

stock-summary
Industry P/E

41

stock-summary
Dividend Yield

1.89%

stock-summary
Debt Equity

-0.34

stock-summary
Return on Equity

11.07%

stock-summary
Price to Book

2.25

Revenue and Profits (1 Year):
Net Sales:
169 Cr
(Quarterly Results - Dec 2024)
Net Profit:
38 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.89%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-43.05%
0%
-43.05%
1 Year
-23.44%
1.29%
-22.15%
2 Years
8.98%
3.66%
12.64%
3 Years
-12.6%
4.00%
-8.6%
4 Years
-25.39%
2.63%
-22.76%
5 Years
97.29%
8.24%
105.53%

Latest dividend: 1.1 per share ex-dividend date: Jul-18-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.16%
EBIT Growth (5y)
-1.20%
EBIT to Interest (avg)
75.14
Debt to EBITDA (avg)
0.17
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.47
Tax Ratio
25.29%
Dividend Payout Ratio
42.78%
Pledged Shares
0
Institutional Holding
20.75%
ROCE (avg)
22.40%
ROE (avg)
11.73%
Valuation key factors
Factor
Value
P/E Ratio
21
Industry P/E
41
Price to Book Value
2.25
EV to EBIT
15.18
EV to EBITDA
12.52
EV to Capital Employed
2.90
EV to Sales
4.08
PEG Ratio
7.21
Dividend Yield
1.89%
ROCE (Latest)
18.98%
ROE (Latest)
11.07%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 8 Schemes (5.57%)

FIIs

Held by 100 FIIs (12.58%)

Promoter with highest holding

Vasant Rathi (33.03%)

Highest Public shareholder

Orbimed Asia Iii Mauritius Fvci Limited (12.07%)

Individual Investors Holdings

16.11%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 5.08% vs 13.25% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -9.86% vs 41.88% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "169.11",
          "val2": "160.94",
          "chgp": "5.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "55.25",
          "val2": "53.76",
          "chgp": "2.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.94",
          "val2": "0.68",
          "chgp": "38.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "37.65",
          "val2": "41.77",
          "chgp": "-9.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.67%",
          "val2": "33.40%",
          "chgp": "-0.73%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -1.47% vs 17.44% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 5.96% vs 43.42% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "300.62",
          "val2": "305.12",
          "chgp": "-1.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "93.58",
          "val2": "95.33",
          "chgp": "-1.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.80",
          "val2": "1.40",
          "chgp": "28.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "66.99",
          "val2": "63.22",
          "chgp": "5.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "31.13%",
          "val2": "31.24%",
          "chgp": "-0.11%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 0.79% vs 15.96% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -0.33% vs 42.80% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "469.73",
          "val2": "466.06",
          "chgp": "0.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "148.83",
          "val2": "149.09",
          "chgp": "-0.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.74",
          "val2": "2.08",
          "chgp": "31.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "104.64",
          "val2": "104.99",
          "chgp": "-0.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "31.68%",
          "val2": "31.99%",
          "chgp": "-0.31%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 15.39% vs 2.13% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 26.19% vs -11.66% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "623.87",
          "val2": "540.64",
          "chgp": "15.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "204.46",
          "val2": "156.45",
          "chgp": "30.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.93",
          "val2": "2.42",
          "chgp": "21.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-15.13",
          "val2": "-4.06",
          "chgp": "-272.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "133.31",
          "val2": "105.64",
          "chgp": "26.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.77%",
          "val2": "28.94%",
          "chgp": "3.83%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
169.11
160.94
5.08%
Operating Profit (PBDIT) excl Other Income
55.25
53.76
2.77%
Interest
0.94
0.68
38.24%
Exceptional Items
0.00
0.00
Consolidate Net Profit
37.65
41.77
-9.86%
Operating Profit Margin (Excl OI)
32.67%
33.40%
-0.73%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 5.08% vs 13.25% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is -9.86% vs 41.88% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
300.62
305.12
-1.47%
Operating Profit (PBDIT) excl Other Income
93.58
95.33
-1.84%
Interest
1.80
1.40
28.57%
Exceptional Items
0.00
0.00
Consolidate Net Profit
66.99
63.22
5.96%
Operating Profit Margin (Excl OI)
31.13%
31.24%
-0.11%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -1.47% vs 17.44% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 5.96% vs 43.42% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
469.73
466.06
0.79%
Operating Profit (PBDIT) excl Other Income
148.83
149.09
-0.17%
Interest
2.74
2.08
31.73%
Exceptional Items
0.00
0.00
Consolidate Net Profit
104.64
104.99
-0.33%
Operating Profit Margin (Excl OI)
31.68%
31.99%
-0.31%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 0.79% vs 15.96% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -0.33% vs 42.80% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
623.87
540.64
15.39%
Operating Profit (PBDIT) excl Other Income
204.46
156.45
30.69%
Interest
2.93
2.42
21.07%
Exceptional Items
-15.13
-4.06
-272.66%
Consolidate Net Profit
133.31
105.64
26.19%
Operating Profit Margin (Excl OI)
32.77%
28.94%
3.83%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 15.39% vs 2.13% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 26.19% vs -11.66% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Advanced Enzyme Technologies Ltd stock-summary
stock-summary
Advanced Enzyme Technologies Ltd
Small Cap
Chemicals
Advanced Enzyme Technologies Limited (AETL) is largest Indian enzyme company that has transformed business globally in the manufacturing and sale of enzymes. Advanced Enzyme Technologies Limited was incorporated, as a Private Company on March 15, 1989 as 'Advanced Biochemicals Private Limited' in Maharashtra. The Company thereafter, got converted into a Public Company and the name of the Company changed to Advanced Biochemicals Limited on May 28, 1992.
Company Coordinates stock-summary
Company Details
Sun Magnetica 5th Floor, Nr LIC Serivce Road Louiswadi Thane Maharashtra : 400604
stock-summary
Tel: 91-22-41703200
stock-summary
http://www.advancedenzymes.com
stock-summary
info@advancedenzymes.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."